World Journal of Diabetes

Bariatric surgery offers the best health results in overweight and obese patients but is not a risk and/or complication-free treatment. In cases with additional hyperglycemia, the burden of surgery can be even higher and alter both short-term and long-term outcomes. Although bariatric surgery offers glycemic improvements and in the case of early onset diabetes disease remission, weight loss results are lower than for obese patients without diabetes. Different multimodal programs, usually including interventions related to patients’ performance, nutritional and psychological status as well as currently available pharmacotherapy before the surgery itself might considerably improve the immediate and late postoperative course. However, there are still no clear guidelines addressing the prehabilitation of obese patients with dysglycemia undergoing bariatric surgery and therefore no unique protocols to improve patients’ health. In this minireview, we summarize the current knowledge on prehabilitation before bariatric surgery procedures in patients with obesity and dysglycemia.

[1]  M. Bała,et al.  Psychological Interventions and Bariatric Surgery among People with Clinically Severe Obesity—A Systematic Review with Bayesian Meta-Analysis , 2022, Nutrients.

[2]  C. Jung,et al.  The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS? , 2022, Journal of obesity & metabolic syndrome.

[3]  D. Pellegrino,et al.  Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery , 2021, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

[4]  A. Wägner,et al.  Prehabilitation for Bariatric Surgery: A Randomized, Controlled Trial Protocol and Pilot Study , 2021, Nutrients.

[5]  J. Rosenstock,et al.  Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. , 2021, The New England journal of medicine.

[6]  K. Boye,et al.  Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data. , 2021, Journal of diabetes and its complications.

[7]  F. Greenway,et al.  Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. , 2021, JAMA.

[8]  T. Wadden,et al.  Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial , 2021, The Lancet.

[9]  T. Wadden,et al.  Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. , 2021, JAMA.

[10]  T. Wadden,et al.  Once-Weekly Semaglutide in Adults with Overweight or Obesity. , 2021, The New England journal of medicine.

[11]  K. Boye,et al.  Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity. , 2020, Journal of diabetes and its complications.

[12]  Natalie Z M Eichner,et al.  Impact of Pre-operative Aerobic Exercise on Cardiometabolic Health and Quality of Life in Patients Undergoing Bariatric Surgery , 2020, Frontiers in Physiology.

[13]  L. Busetto,et al.  Reviews in endocrine and metabolic disorders. , 2020, Reviews in endocrine & metabolic disorders.

[14]  Rajesh Gupta,et al.  Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study , 2020, Obesity Surgery.

[15]  Jae Hyun Kim,et al.  Current Long-Term Pharmacotherapies for the Management of Obesity , 2020, Journal of obesity & metabolic syndrome.

[16]  S. Pouwels,et al.  Perioperative Exercise Therapy in Bariatric Surgery: Improving Patient Outcomes , 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.

[17]  C. Ritz,et al.  Predictors of weight loss after bariatric surgery—a cross-disciplinary approach combining physiological, social, and psychological measures , 2020, International Journal of Obesity.

[18]  M. Moya-Ramón,et al.  Impact of Exercise on Body Composition and Cardiometabolic Risk Factors in Patients Awaiting Bariatric Surgery. , 2019, Obesity surgery.

[19]  S. Pouwels,et al.  Utility of preoperative exercise therapy in reducing postoperative morbidity after surgery; a clinical overview of current evidence , 2019, Expert review of cardiovascular therapy.

[20]  J. Fisher,et al.  Is interval training the magic bullet for fat loss? A systematic review and meta-analysis comparing moderate-intensity continuous training with high-intensity interval training (HIIT) , 2019, British Journal of Sports Medicine.

[21]  P. Tynelius,et al.  Meeting physical activity recommendations is associated with health-related quality of life in women before and after Roux-en-Y gastric bypass surgery , 2019, Quality of Life Research.

[22]  A. Schneck,et al.  Correcting micronutrient deficiencies before sleeve gastrectomy may be useful in preventing early postoperative micronutrient deficiencies. , 2019, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[23]  M. Pędziwiatr,et al.  Influence of Preoperative Weight Loss on Outcomes of Bariatric Surgery for Patients Under the Enhanced Recovery After Surgery Protocol , 2019, Obesity Surgery.

[24]  K. Khunti,et al.  Meta‐analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes , 2018, The British journal of surgery.

[25]  Arya M. Sharma,et al.  Use of Liraglutide in a Tertiary Bariatric Clinic: A Case Series , 2019, Journal of Obesity and Chronic Diseases.

[26]  R. Gimeno,et al.  LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept , 2018, Molecular metabolism.

[27]  R. Vettor,et al.  Pre-operative Very Low Calorie Ketogenic Diet (VLCKD) vs. Very Low Calorie Diet (VLCD): Surgical Impact , 2018, Obesity Surgery.

[28]  J. Salas-Salvadó,et al.  Effects of Two Preoperatory Weight Loss Diets on Hepatic Volume, Metabolic Parameters, and Surgical Complications in Morbid Obese Bariatric Surgery Candidates: a Randomized Clinical Trial , 2018, Obesity Surgery.

[29]  P. O'Neil,et al.  Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial , 2018, The Lancet.

[30]  Arya M. Sharma,et al.  Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery , 2018, Obesity Surgery.

[31]  L. Cobellis,et al.  Metabolic effects, safety, and acceptability of very low-calorie ketogenic dietetic scheme on candidates for bariatric surgery. , 2018, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[32]  M. Langlois,et al.  Effects of a Pre-surgery Supervised Exercise Training 1 Year After Bariatric Surgery: a Randomized Controlled Study , 2018, Obesity Surgery.

[33]  Jennifer L. Kirby,et al.  Bariatric Surgery Resistance: Using Preoperative Lifestyle Medicine and/or Pharmacology for Metabolic Responsiveness , 2017, Obesity Surgery.

[34]  Raymond L. Forbes,et al.  3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial , 2017, The Lancet.

[35]  C. Neumann,et al.  What Is the Best Treatment before Bariatric Surgery? Exercise, Exercise and Group Therapy, or Conventional Waiting: a Randomized Controlled Trial , 2017, Obesity Surgery.

[36]  Florence E. Turrentine,et al.  Type 2 diabetes remission following gastric bypass: does diarem stand the test of time? , 2017, Surgical Endoscopy.

[37]  J. Teijink,et al.  Preoperative exercise therapy in surgical care: a scoping review. , 2016, Journal of clinical anesthesia.

[38]  M. Langlois,et al.  Impacts of Supervised Exercise Training in Addition to Interdisciplinary Lifestyle Management in Subjects Awaiting Bariatric Surgery: a Randomized Controlled Study , 2016, Obesity Surgery.

[39]  B. Goodpaster,et al.  Dose-Response of Exercise Training following Roux-en-Y gastric bypass surgery: A randomized trial , 2015, Obesity.

[40]  T. Magnuson,et al.  Malnutrition in Bariatric Surgery Candidates: Multiple Micronutrient Deficiencies Prior to Surgery , 2015, Obesity Surgery.

[41]  J. DeLany,et al.  Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. , 2015, JAMA surgery.

[42]  R. DeFronzo,et al.  Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial. , 2015, JAMA.

[43]  A. Astrup,et al.  A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. , 2015, The New England journal of medicine.

[44]  Jacob C. Seidell,et al.  The Global Burden of Obesity and the Challenges of Prevention , 2015, Annals of Nutrition and Metabolism.

[45]  Deepak L. Bhatt,et al.  Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery , 2014, Obesity.

[46]  W. Strodel,et al.  Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis. , 2015, Annals of surgery.

[47]  R. Wing,et al.  Bari-Active: a randomized controlled trial of a preoperative intervention to increase physical activity in bariatric surgery patients. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[48]  Deepak L. Bhatt,et al.  Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non‐remission status after bariatric surgery , 2014, Diabetes, obesity & metabolism.

[49]  L. Aronne,et al.  Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study , 2014, International Journal of Obesity.

[50]  C. Datz,et al.  Obesity as an Emerging Risk Factor for Iron Deficiency , 2014, Nutrients.

[51]  N. Xu,et al.  Predictive Factors of Type 2 Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis , 2014, Obesity Surgery.

[52]  S. Wonderlich,et al.  Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews. , 2014, Comprehensive psychiatry.

[53]  G. Silecchia,et al.  Very Low-Carbohydrate Ketogenic Diet Before Bariatric Surgery: Prospective Evaluation of a Sequential Diet , 2014, Obesity Surgery.

[54]  L. Aronne,et al.  Effects of Late Gestational High Fat Diet on Body Weight, Metabolic Regulation and Adipokine Expression in Offspring , 2013, International Journal of Obesity.

[55]  Daniel B. Jones,et al.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery* , 2013, Obesity.

[56]  Daniel B. Jones,et al.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery* , 2013, Obesity.

[57]  M. Langlois,et al.  Feasibility and Impacts of Supervised Exercise Training in Subjects with Obesity Awaiting Bariatric Surgery: a Pilot Study , 2013, Obesity Surgery.

[58]  R. Arena,et al.  Effects of aerobic exercise training on variability and heart rate kinetic during submaximal exercise after gastric bypass surgery – a randomized controlled trial , 2013, Disability and rehabilitation.

[59]  P. Schauer,et al.  Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[60]  B. Geloneze,et al.  Comparison of Metabolic Effects of Surgical-Induced Massive Weight Loss in Patients with Long-Term Remission Versus Non-remission of Type 2 Diabetes , 2012, Obesity Surgery.

[61]  P. O’Brien,et al.  Does Exercise Improve Weight Loss after Bariatric Surgery? A Systematic Review , 2012, Obesity Surgery.

[62]  A. Shulkes,et al.  Long-term persistence of hormonal adaptations to weight loss. , 2011, The New England journal of medicine.

[63]  E. Livingston,et al.  High‐Volume Exercise Program in Obese Bariatric Surgery Patients: A Randomized, Controlled Trial , 2011, Obesity.

[64]  Iseu Gus,et al.  Impacto de um programa mínimo de exercícios físicos supervisionados no risco cardiometabólico de pacientes com obesidade mórbida , 2011 .

[65]  C. Neumann,et al.  [Impact of a minimum program of supervised exercises in the cardiometabolic risk in patients with morbid obesity]. , 2011, Arquivos brasileiros de endocrinologia e metabologia.

[66]  R. Wing,et al.  Pre‐ to Postoperative Physical Activity Changes in Bariatric Surgery Patients: Self Report vs. Objective Measures , 2010, Obesity.

[67]  I-Min Lee,et al.  Physical Activity and Cardiovascular Health: Lessons Learned From Epidemiological Studies Across Age, Gender, and Race/Ethnicity , 2010, Circulation.

[68]  M. Pellen,et al.  Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity , 2010, Obesity surgery.

[69]  A. Rissanen,et al.  Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. , 2008, European journal of endocrinology.

[70]  E. Aasheim,et al.  Vitamin status in morbidly obese patients: a cross-sectional study. , 2008, The American journal of clinical nutrition.

[71]  C. Apovian,et al.  Weight Loss and Health Outcomes in African Americans and Whites After Gastric Bypass Surgery , 2007, Obesity.

[72]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[73]  Julia N. Soulakova,et al.  Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. , 2007, The American journal of psychiatry.

[74]  N. Abumrad,et al.  Is roux-en-y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? , 2005, Journal of Gastrointestinal Surgery.

[75]  J. Kelly,et al.  Predictors of Weight Status following Laparoscopic Gastric Bypass , 2006, Obesity surgery.

[76]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[77]  D. Warburton,et al.  Health benefits of physical activity: the evidence , 2006, Canadian Medical Association Journal.

[78]  J. Hebebrand,et al.  Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. , 2004, Obesity research.

[79]  D. Krahn,et al.  Long-term Follow-up of Patients' Status after Gastric Bypass , 2001, Obesity surgery.

[80]  N. Scopinaro,et al.  Binge eating in massively obese patients undergoing bariatric surgery. , 1995, The International journal of eating disorders.